Friday 6 November 2026
Export ZBH’s income statement to Excel — free account
Zimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.
- Revenue
- +3.07%
- EPS
- −13.5%
- Free cash flow
- +29.8%
- Total debt
- −7.50%
Quarter to September 2026, against a year earlier
105.28
1.57
−1.47%
Follow ZBH
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 6 | 6 |
| 5.60% | 6.07% | 6.41% | 6.02% | ||
| 3.17% | 3.39% | 3.53% | 3.26% | ||
ROIC |
3.50% | 3.74% | 3.82% | 3.66% | |
Return on Tangible Assets |
14.87% | 17.66% | 18.67% | 19.49% | |
Average Days of Receivables |
75.58 | 75.03 | 75.91 | 77.34 | |
Free Cash Flow per Share |
5.44 | 5.17 | 5.39 | 5.86 | |
Free Cash Flow |
1,077.30 | 1,008.10 | 1,036.50 | 1,116.20 | |
Capital Expenditures |
(619.80) | (665.60) | (706.80) | (768.40) | |
| Other line items | |||||
Cash ROIC |
5.18% | 4.90% | 5.05% | 5.41% | |
Accounts Receivable Turnover |
5.17 | 5.16 | 5.03 | 5.02 | |
Accounts Payable Turnover |
10.02 | 7.61 | 7.31 | 7.72 | |
Inventory Turnover |
1.10 | 1.12 | 1.09 | 1.07 | |
Average Days of Payables |
44.35 | 52.31 | 50.18 | 0.00 | |
Days of Inventory on Hand |
334.66 | 325.42 | 323.27 | 332.50 | |
Tax Rate |
(0.15) | (0.16) | (0.14) | (0.13) | |
Research and Development Expense of Revenue |
5.57% | 5.37% | 5.20% | 5.05% | |
Selling, General and Administrative Expense of Revenue |
39.57% | 39.82% | 40.34% | 40.56% | |
Share Based Compensation of Revenue |
1.10% | 1.13% | 1.15% | 1.13% | |
Interest Coverage |
3.75 | 3.99 | 4.17 | 4.03 | |
Operating CF/Net income |
2.41 | 2.20 | 2.16 | 2.46 | |
Depreciation/Fixed assets |
0.50 | 0.50 | 0.50 | 0.48 | |
Capex/Depreciation |
(0.57) | (0.60) | (0.64) | (0.69) | |
Revenue per Share |
41.57 | 43.12 | 44.27 | 44.99 | |
Operating CF per Share |
8.57 | 8.58 | 9.07 | 9.89 | |
Capex per Share |
(3.13) | (3.41) | (3.68) | (4.03) | |
Capex to Sales |
0.08 | 0.08 | 0.08 | 0.09 |
Columns are period end dates · fundamentals updated 5 Nov 2026